Results 131 to 140 of about 63,132 (220)

Current Strategies for Selecting Recombinant Orthopoxvirus Proteins for Immunobiological and Diagnostic Applications. [PDF]

Viruses
Zhakypbek A, Kutumbetov L, Kuzembekova G, Shorayeva K, Kozhabergenov N, Usserbayev B, Nakhanova G, Jekebekov K, Shynybekova G, Abdykalyk A, Ulankyzy A, Baiseit T, Myrzakhmetova B, Chervyakova O, Zhugunissov K.   +14 more
europepmc   +1 more source

Montine Vaccinia

International Journal of Clinical Practice, 1957
openaire   +2 more sources

Structure and functional analyses of vaccinia virus J5 protein reveal distinct determinants for entry-fusion complex assembly and activation. [PDF]

J Virol
Chiu H-J, Carillo KJ, Hsieh LT-H, Lou Y-C, Lin CS-H, Tzou D-L, Chang W.   +6 more
europepmc   +1 more source

Vaccinia virus growth factor induces divergent signaling programs and biological outcomes from cellular epidermal growth factor. [PDF]

PLoS Pathog
Pant A, Dsouza L, Yang Z.
europepmc   +1 more source

Multi-pathogen and combination vaccines for biodefense pathogens. [PDF]

Front Immunol
Clarke EC, Kidner RQ, Montoya MM, Lenz KD, Kubicek-Sutherland JZ, Bradfute SB.   +5 more
europepmc   +1 more source

Mitochondrial checkpoint for interferon responses in macrophages. [PDF]

Explor Target Antitumor Ther
Mieland AO, Krämer OH.
europepmc   +1 more source

Whence Feral Vaccinia?

Emerging Infectious Diseases, 2010
Richard C. Condit
doaj   +1 more source

Interleukin-21 expressing oncolytic vaccinia virus elicits systemic anti-tumor immune response and synergizes with immunotherapies. [PDF]

Mol Ther Oncol
Zhang R, Wang T, Wang Y, Hong C, Qin Y, Ye K, Zhao H, Hu F, Cai J, Fu J.   +9 more
europepmc   +1 more source

ACCIDENTAL VACCINIA [PDF]

British Journal of Ophthalmology, 1957
openaire   +2 more sources

Vaccinia Gangrenosa: The Report of a Case of Prolonged Generalized Vaccinia [PDF]

Archives of Disease in Childhood, 1952
B, LAURANCE, A C, CUNLIFFE, J A, DUDGEON
openaire   +2 more sources